CY1110154T1 - Μεθοδοι διαλογης για παραγοντες ενισχυσης γνωστικων ικανοτητων - Google Patents

Μεθοδοι διαλογης για παραγοντες ενισχυσης γνωστικων ικανοτητων

Info

Publication number
CY1110154T1
CY1110154T1 CY20101100580T CY101100580T CY1110154T1 CY 1110154 T1 CY1110154 T1 CY 1110154T1 CY 20101100580 T CY20101100580 T CY 20101100580T CY 101100580 T CY101100580 T CY 101100580T CY 1110154 T1 CY1110154 T1 CY 1110154T1
Authority
CY
Cyprus
Prior art keywords
knowledge
cognitive
dialogue methods
strengthening factors
function
Prior art date
Application number
CY20101100580T
Other languages
English (en)
Inventor
Timothy P Tully
Roderick EM SCOTT
Rusiko Bourtchouladze
Original Assignee
Helicon Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03788648A external-priority patent/EP1540335B1/en
Application filed by Helicon Therapeutics, Inc. filed Critical Helicon Therapeutics, Inc.
Publication of CY1110154T1 publication Critical patent/CY1110154T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η παρούσα εφεύρεση δίδει μεθόδους για ταυτοποίηση γνωστικών ενισχυτών ικανών να ενισχύουν την λειτουργία των οδών CREB. Οι γνωστικοί ενισχυτές, που ταυτοποιούνται σύμφωνα με την εφεύρεση μπορούν να χρησιμοποιηθούν για την αποκατάσταση ενός ζώου με γνωστικές δυσλειτουργίες και για την ενίσχυση της μνήμης ή της κανονικής γνωστικής συμπεριφοράς (ικανότητα ή λειτουργία) εις ένα κανονικό ζώο.
CY20101100580T 2002-08-19 2010-06-24 Μεθοδοι διαλογης για παραγοντες ενισχυσης γνωστικων ικανοτητων CY1110154T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40462002P 2002-08-19 2002-08-19
US40640502P 2002-08-26 2002-08-26
EP03788648A EP1540335B1 (en) 2002-08-19 2003-08-19 Screening methods for cognitive enhancers

Publications (1)

Publication Number Publication Date
CY1110154T1 true CY1110154T1 (el) 2015-01-14

Family

ID=43034205

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100580T CY1110154T1 (el) 2002-08-19 2010-06-24 Μεθοδοι διαλογης για παραγοντες ενισχυσης γνωστικων ικανοτητων

Country Status (1)

Country Link
CY (1) CY1110154T1 (el)

Similar Documents

Publication Publication Date Title
CY1118935T1 (el) Παρακολουθηση της καταστασης συστηματος χρησιμοποιωντας μια μηχανη επαναληπτικης τοπικης εκμαθησης
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
ATE444377T1 (de) Nukleinsäurecharakterisierung
HK1143406A1 (en) Screening methods for cognitive enhancers
DK1158459T3 (da) Fremgangsmåde, indretning og sikkerhedssystem, alle til at berigtige en markering
TR200201887T2 (tr) Sulu elastomer kaplama bileşimi ve bununla kaplanmış cisimler.
DE602004019812D1 (de) Marker für neuromyelitis optica
ATE400133T1 (de) Selbstverwalteter vermittelter informationsfluss
DK1780043T3 (da) Informationsside og en fremgangsmåde
EA200300880A1 (ru) Способ детекции нуклеотидного полиморфизма
ITVA20020050A1 (it) Metodo e circuito di amplificazione con pre-enfasi.
CY1107297T1 (el) Συνθεση με μυκητοκτονο δραση με βαση αλας καλιου του φωσφορωδους οξεος (potassium acid phosphite)
BR0115675A (pt) Métodos para determinar a contribuição da superfìcie à aparência de um objeto em particular, para predizer a aparência de um objeto e para manufaturar um objeto tendo uma aparência pré-determinada que tenha sido opcionalmente determinada com base em um objeto de referência
DE60217652D1 (de) Kit und verfahren zum nachweis von fäkalen parasiten
DK1246945T3 (da) Fremgangsmåde til identifikation af en mærkning anbragt på et fast legeme
CY1110154T1 (el) Μεθοδοι διαλογης για παραγοντες ενισχυσης γνωστικων ικανοτητων
ES2233695T3 (es) Composicion que retarda el enrejillado.
CY1113775T1 (el) Συσκευη αγωγης μεσω της εκπομπης φωτεινων αναλαμπων, ιδιαιτερα για αποτριχωση
DK1565490T3 (da) Holo-transcobalamin bindingspartnere og deres anvendelse i cobalamintest
DE60117591D1 (de) Verfahren zum nachweis von serine/threonine kinase aktivität
EA200500878A1 (ru) Кальцилитические соединения
IS7441A (is) Peptíðdeformýlasatálmar
ATE490502T1 (de) Prozessor mit adressengenerator
TR200501010T2 (tr) Mikobakteri türlerinin saptanması için moleküler boy belirleyicileri
BRPI0418183A (pt) ensaios bioluminescentes e células úteis nos mesmos